Table 2.
ΔS drug sensitivity for compounds affecting the PI3K/AKT/mTOR pathway, sorted by the ΔS mean from all four PNF1 cell lines.
PI3KCA | AKT1 | MTOR | ||||||
---|---|---|---|---|---|---|---|---|
Compound | ΔS Mean |
ΔS Variance |
Compound | ΔS Mean |
ΔS Variance |
Compound | ΔS Mean |
ΔS Variance |
GNE-490 | −0.66 | 0.25 | Triciribine-PO4 | −1.51 | 0.81 | WYE-354 | −0.53 | 1.15 |
NIBR-17 | −0.48 | 0.14 | A-443654 | −0.82 | 0.04 | AZD-2014 | −0.34 | 0.24 |
PIK-90 | −0.45 | 0.01 | AT-7867 | −0.62 | 0.16 | GDC-0980 | −0.24 | 0.14 |
BKM-120 | −0.33 | 0.47 | AZD-5363 | −0.36 | 0.10 | KU-0063794 | −0.23 | 0.04 |
PF-04691502 | −0.31 | 0.20 | GDC-0068 | −0.34 | 0.12 | AZD-8055 | −0.22 | 0.38 |
GNE-493 | −0.28 | 0.08 | H-89 | −0.26 | 0.12 | WAY-600 | −0.20 | 0.19 |
PIK-93 | −0.28 | 0.23 | MK-2206 | −0.13 | 0.02 | PP-242 | −0.20 | 0.89 |